Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-10-16

FDA Approved: ALLOPURINOL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA granted a supplemental approval for ALLOPURINOL submitted by Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc. to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)

Snippet

SUPPL AP for ALLOPURINOL (ALLOPURINOL)